Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation

US6403597B1 · kind B1 · utility

Assignee

• Vivus, Inc. · US

Inventors

• Leland F. Wilson · Menlo Park, US
• Paul C. Doherty, Jr. · Cupertino, US
• Virgil A. Place · Kawaihae, US
• William L. Smith · Mahwah, US
• Ibrahim AbouBakr Abdel-Hamid Abdou Ali · Mansoura, EG

Key dates

• Filing date: Jun 21, 2001
• Grant date: Jun 11, 2002
• Expiry date: Jun 21, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method is provided for treatment of premature ejaculation by administration of a phosphodiesterase inhibitor, e.g., an inhibitor of a Type III, Type IV, or Type V phosphodiesterase. In a preferred embodiment, administration is on as “as needed” basis, i.e., the drug is administered immediately or several hours prior to sexual activity. Pharmaceutical formulations and packaged kits are also provided.